Skip to main content


Firm Analyst
Canaccord Genuity
John   Newman
Chardan Capital Markets
Taylor   Feehley
Chris   Shibutani
Goldman Sachs
Terence   Flynn
Mark   Breidenbach

Seres Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Seres Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Seres Therapeutics, Inc. or its management. Seres Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Back to top